superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2018-09-30
- Valid until
- 2018-12-31
- Published
- 2018-10-31
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 12,500,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Amgen total equity: 14,349,000,000 United States dollar", as of 2018-09-30 (until 2018-12-31). Claim clm_08B4799386AF, https://asof.is/claim/clm_08B4799386AF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815418000022/0000318154-18-000022-index.htm.
APA
AsOf. (2018). Amgen total equity: 14,349,000,000 United States dollar (as of 2018-09-30 (until 2018-12-31)) [Record clm_08B4799386AF]. Retrieved November 9, 2026, from https://asof.is/claim/clm_08B4799386AF (source: https://www.sec.gov/Archives/edgar/data/318154/000031815418000022/0000318154-18-000022-index.htm)
BibTeX
@misc{asof_clm_08B4799386AF,
author = {AsOf},
title = {Amgen total equity: 14,349,000,000 United States dollar},
year = {2018},
howpublished = {\url{https://asof.is/claim/clm_08B4799386AF}},
note = {Claim clm\_08B4799386AF, as of 2018-09-30 (until 2018-12-31); source: https://www.sec.gov/Archives/edgar/data/318154/000031815418000022/0000318154-18-000022-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_08B4799386AF.md/v1/claims/clm_08B4799386AFsubmit a correction